MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Short Interest Up 163.2% in August

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) was the recipient of a large growth in short interest in August. As of August 31st, there was short interest totalling 10,000 shares, a growth of 163.2% from the August 15th total of 3,800 shares. Based on an average daily volume of 54,700 shares, the short-interest ratio is currently 0.2 days.

MERCK Kommanditgesellschaft auf Aktien stock traded down $0.45 during mid-day trading on Friday, hitting $46.38. The stock had a trading volume of 33,685 shares, compared to its average volume of 52,048. The firm’s 50 day moving average is $44.48 and its 200 day moving average is $38.39. MERCK Kommanditgesellschaft auf Aktien has a one year low of $28.59 and a one year high of $49.08.

Several equities research analysts have recently commented on the company. UBS Group lowered MERCK Kommanditgesellschaft auf Aktien from a “neutral” rating to a “sell” rating in a research note on Tuesday. Societe Generale restated a “hold” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a research note on Friday, August 6th. Credit Suisse Group reaffirmed an “outperform” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a report on Friday, August 6th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a report on Friday, September 10th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a report on Monday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, MERCK Kommanditgesellschaft auf Aktien presently has a consensus rating of “Hold”.

MERCK Kommanditgesellschaft auf Aktien Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility.

Further Reading: What is Considered a Good Return on Equity (ROE)?

Receive News & Ratings for MERCK Kommanditgesellschaft auf Aktien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK Kommanditgesellschaft auf Aktien and related companies with MarketBeat.com's FREE daily email newsletter.